Procyon Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Procyon Advisors's AMGN Position: Q3 2026 in Review
Procyon Advisors reduced its Amgen (AMGN) stake by 2% in Q3 2026, selling an estimated $54.6K and leaving 6,713 shares worth $2.83M. The position accounts for 0.12% of the portfolio, ranked #167.
Procyon Advisors first reported a position in AMGN in Q4 2019 and has held it in 28 quarters since. The position peaked at $3.32M in Q1 2025. 1,494 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Procyon Advisors held 6,713 shares of Amgen worth $2.83M as of Q3 2026.
- Procyon Advisors sold 137 Amgen shares in Q3 2026, an estimated $54.6K.
- Amgen made up 0.12% of Procyon Advisors's portfolio in Q3 2026, its #167 holding.
- Procyon Advisors first reported a position in Amgen in Q4 2019 and has held it in 28 quarters since.
- Procyon Advisors's Amgen position peaked at $3.32M in Q1 2025.
- 1,494 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.